To what extent can pharmaceutical counterfeiting ever be contained?
Thu 24 Jun 2010 3pm UK, 4pm Europe Summer Time, 10am USA Eastern
In recent years the rise in high-profile seizures of counterfeit drugs has served to highlight the unprecedented pressure on the drugs value chain.
In this session we:
- Ask whether the war against the counterfeiters is being won?
- Consider what the implications are of current and future legislation at national, regional and global levels
- Assess the ability of existing technology to meet the challenge and predict fruitful areas of future development
- Discuss ways in which the industry can collaborate to protect the integrity of the pharma supply chain
Speakers
Marisa Matias, MEP
Rapporteur - Counterfeit Medicines, European Parliament
Member of the European Parliament
Janice M. Soreth
Deputy Director, FDA Europe Office
Janice Soreth is Deputy Director of the US FDA’s Europe Office, coordinating FDA activities in Europe for medical products (human and veterinary drugs, biologics, and devices). She is seconded to the European Medicines Agency and resides in London. She directed FDA’s Division of Anti-Infectives and Ophthalmology from 2000-2007 and served as a general internist in the US Public Health Service.
Guy Villax
Guy Villax has been the Chief Executive Officer of Hovione since 1997. Prior to that, he held positions with Price Waterhouse in London and Hovione in the Far East. He has a degree in Accounting and Financial Management from the University College at Buckingham. He is a member of the board of CEFIC’s European Fine Chemicals Group www.efcg.cefic.org and of RX-360 , the International Pharmaceutical Supply Chain Consortium www.rx-360.org
Mark Davison
Pharmaceutical Consultant & Writer, Session Chair
Mark Davison is a pharmaceutical security consultant with extensive knowledge of counterfeiting issues worldwide and the technology approaches needed to address them. His forthcoming book on the subject will be published by Wiley in late 2010. Mark was latterly responsible for the healthcare business of one of the world’s leading security technology companies. Prior to that, he gained wide experience in the pharmaceutical industry at GlaxoSmithKline as well as in associated service industries (Charles River, Quintiles Transnational) and at several biotechnology start-ups. Mark is a Fellow of the Royal Society of Medicine and a Member of the Institute of Clinical Research. Read his regular blog at www.pharmapieces.com
Media Partners
SecuringPharma.com is a free-to-access information service that covers the issues surrounding counterfeit medicines and supply chain security in the pharmaceutical industry. Our aim is to provide practical advice and market intelligence to help drug-makers keep up-to-date with developments in the field and define their own strategies to safeguard the supply chain, from raw materials right through to the patient.
PharmiWeb.com is the leading industry-sponsored portal for news and jobs in the pharmaceutical sector. Search thousands of constantly updated jobs. Subscribe to job alerts or RSS feeds.